FACTORS OF ENDOMETRIAL RECEPTIVITY DOWN-REGULATION IN GENITAL ENDOMETRIOSIS
article
OA: diamond
CC0
⤵ 1 in-corpus citation
AI-generated summary
This review analyzes literature and own studies on factors and markers of decreased eutopic endometrial receptivity and pain manifestations in women with genital endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis, or endometrioid disease, is a chronic estrogen-dependent gynecological disease caused by ectopic localization of endometrial tissue, mainly in the pelvis and ovaries. However, at the present stage of development of reproductive medicine, the classical topographic definition of endometriosis should be expanded with new significant characteristics established using the achievements of cell and molecular biology, which allowed a more detailed study of the pathogenesis of this disease. In addition, the introduction of personalized approaches to the treatment of patients with endometriosis and infertility, more attention should be paid to the search for disease predictors and the formation of risk groups with the observation of patients from puberty to menopause. In this review, we have analyzed the literature data and our own studies with an emphasis on factors and markers of decreased receptivity of eutopic endometrium in women with endometriosis, as well as pain, the manifestations of which can contribute to the exact diagnosis of external genital endometriosis.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (45)
- Absence of aromatase protein and mRNA expression in endometriosis via openalex
- Adenomyosis and endometriosis have a common origin via openalex
- Analysis of pain manifestations in extragenital endometriosis stage I–IV via openalex
- Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: New questions—old answers? via openalex
- Aromatase inhibitors: the next generation of therapeutics for endometriosis? via openalex
- Bacterial contamination hypothesis: a new concept in endometriosis via openalex
- Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy via openalex
- Chronic endometritis with normal and thin endometrium during treatment of reproductive-age women: ultrasound and histological correlations via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why via openalex
- Endometriosis via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Eutopic Endometrium From Women With Endometriosis Shows Altered Ultrastructure and Glycosylation Compared to That From Healthy Controls—A Pilot Observational Study via openalex
- Eutopic Endometrium in Women with Endometriosis: Ground Zero for the Study of Implantation Defects via openalex
- Expression Profiling of Endometrium from Women with Endometriosis Reveals Candidate Genes for Disease-Based Implantation Failure and Infertility via openalex
- Gene Expression Analysis of Endometrium Reveals Progesterone Resistance and Candidate Susceptibility Genes in Women with Endometriosis via openalex
- Higher prevalence of chronic endometritis in women with endometriosis: a possible etiopathogenetic link via openalex
- HOXA-10 expression in the mid-secretory endometrium of infertile patients with either endometriosis, uterine fibromas or unexplained infertility via openalex
- HOXA10 expression is decreased in endometrium of women with adenomyosis via openalex
- Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy via openalex
- Localization of laminin, fibronectin, E-cadherin, and integrins in endometrium and endometriosis via openalex
- Mechanisms of pain in endometriosis via openalex
- Molecular Biology of Endometriosis: From Aromatase to Genomic Abnormalities via openalex
- Optimal uterine anatomy and physiology necessary for normal implantation and placentation via openalex
- Prokineticin 1, homeobox A10, and progesterone receptor messenger ribonucleic acid expression in primary cultures of endometrial stromal cells isolated from endometrium of healthy women and from eutopic endometrium of women with endometriosis via openalex
- Reduced expression of HOXA10 in the midluteal endometrium from infertile women with minimal endometriosis via openalex
- Role of Eutopic Endometrium in Pelvic Endometriosis via openalex
- The Protein Kinase A Pathway-Regulated Transcriptome of Endometrial Stromal Fibroblasts Reveals Compromised Differentiation and Persistent Proliferative Potential in Endometriosis via openalex
- The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions via openalex
- Uterine Lymphatic and Blood Micro-Vessels in Women with Endometriosis through the Menstrual Cycle via openalex
- World Endometriosis Society consensus on the classification of endometriosis via openalex
- W2890354775 via openalex
- W1894499368 via openalex
- W1987201924 via openalex
- W1991793418 via openalex
- W2010310328 via openalex
- W2024418590 via openalex
- W2045461902 via openalex
- W2141008454 via openalex
- W2154920925 via openalex
- W2604541038 via openalex
- W2737085072 via openalex
- W75083049 via openalex
- W2904897743 via openalex
- W2977476106 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK